Cell Therapy Market Report 2023 to 2032 Analysis by Key Raw Materials Price Trend, Manufacturing Cost Structure, and Industrial Chain Analysis
Ngày đăng: 14-08-2023 |
Ngày cập nhật: 14-08-2023
Market Highlights
Cell Therapy Market overview Size was valued at USD 13.5 Billion in 2022. The Cell Therapy market industry is projected to grow from USD 14.8 Billion in 2023 to USD 31.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% during the forecast period (2023 - 2032).
Autologous cell therapy is a branch of regenerative medicine. It involves biologic cell-based therapies to cure various diseases related to oncology, dermatology, and neurology, among others. Autologous cell therapy is anticipated to hold a significant share of the market as compared to allogeneic cell therapy
Americas accounted for the largest market share of 37.6% in 2017, and the regional market is projected to register a CAGR of 21.45% during the forecast period. North America is one of the leading markets in the region, accounting for the largest market share during the review period.
The cell therapy market's rapid expansion is primarily attributed to its potential applications across a wide range of medical conditions. Currently, cell therapy is being explored for the treatment of conditions like cancer, neurodegenerative disorders, cardiovascular diseases, autoimmune disorders, and even genetic disorders. Promising clinical trials and early successes have propelled interest in using cell therapy for conditions like leukemia, where modified immune cells are infused into the patient to target and eliminate cancer cells.
Segment Analysis
By type, the global cell therapy market has been classified as autologous and allogeneic. Autologous cell therapy is anticipated to hold a significant share of the market as compared to allogeneic cell therapy.
Based on product, the global cell therapy market has been classified as consumables (vessel/media/serum/reagent), equipment, software & other services. The increasing occurrences of infectious diseases are the major factor which is likely to drive the growth of the consumables segment during the forecast period.
On the basis of technique the global cell therapy market has been classified as stem cell therapy, cell vaccine, adoptive cell transfer (act), fibroblast cell therapy and chondrocyte cell therapy.
By technology the global cell therapy market has been classified as viral vector technology, cell immortalization technology, and genome editing technology.
Based on cell source the global cell therapy market has been classified as bone marrow, adipose tissue, and umbilical cord blood-derived cells. The rising demand for bone marrow transplantation in the treatment of ischemic heart diseases is expected to drive market growth.
On the basis of application the global cell therapy market has been classified as oncology, cardiovascular disease (CVD), orthopedic and wound healing.
The global cell therapy market has also been segregated, based on end user, into hospital & clinics, regenerative medicine centers, and research institutes.
Regional Analysis
Geographically, the global cell therapy market report has been segmented into North America, Europe, Asia-Pacific, and the rest of the world. As per MRFR analysis, North America holds the largest market for cell therapy in 2017 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The rise in the demand for cell therapy for the treatment of oncology is a major driving factor for the growth of the cell therapy market in Europe.
Key Findings of the Study:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Cell Therapy Market overview Size was valued at USD 13.5 Billion in 2022. The Cell Therapy market industry is projected to grow from USD 14.8 Billion in 2023 to USD 31.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% during the forecast period (2023 - 2032).
Autologous cell therapy is a branch of regenerative medicine. It involves biologic cell-based therapies to cure various diseases related to oncology, dermatology, and neurology, among others. Autologous cell therapy is anticipated to hold a significant share of the market as compared to allogeneic cell therapy
Americas accounted for the largest market share of 37.6% in 2017, and the regional market is projected to register a CAGR of 21.45% during the forecast period. North America is one of the leading markets in the region, accounting for the largest market share during the review period.
The cell therapy market's rapid expansion is primarily attributed to its potential applications across a wide range of medical conditions. Currently, cell therapy is being explored for the treatment of conditions like cancer, neurodegenerative disorders, cardiovascular diseases, autoimmune disorders, and even genetic disorders. Promising clinical trials and early successes have propelled interest in using cell therapy for conditions like leukemia, where modified immune cells are infused into the patient to target and eliminate cancer cells.
Segment Analysis
By type, the global cell therapy market has been classified as autologous and allogeneic. Autologous cell therapy is anticipated to hold a significant share of the market as compared to allogeneic cell therapy.
Based on product, the global cell therapy market has been classified as consumables (vessel/media/serum/reagent), equipment, software & other services. The increasing occurrences of infectious diseases are the major factor which is likely to drive the growth of the consumables segment during the forecast period.
On the basis of technique the global cell therapy market has been classified as stem cell therapy, cell vaccine, adoptive cell transfer (act), fibroblast cell therapy and chondrocyte cell therapy.
By technology the global cell therapy market has been classified as viral vector technology, cell immortalization technology, and genome editing technology.
Based on cell source the global cell therapy market has been classified as bone marrow, adipose tissue, and umbilical cord blood-derived cells. The rising demand for bone marrow transplantation in the treatment of ischemic heart diseases is expected to drive market growth.
On the basis of application the global cell therapy market has been classified as oncology, cardiovascular disease (CVD), orthopedic and wound healing.
The global cell therapy market has also been segregated, based on end user, into hospital & clinics, regenerative medicine centers, and research institutes.
Regional Analysis
Geographically, the global cell therapy market report has been segmented into North America, Europe, Asia-Pacific, and the rest of the world. As per MRFR analysis, North America holds the largest market for cell therapy in 2017 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The rise in the demand for cell therapy for the treatment of oncology is a major driving factor for the growth of the cell therapy market in Europe.
Key Findings of the Study:
- The global cell therapy market is projected to reach over USD 20,217.00 million by 2023 at a 22.36% CAGR during the review period of 2018 to 2023.
- Americas accounted for the largest market share with North America being the major contributor to the growth of the market.
- The autologous segment is projected to register the highest CAGR of 22.00% during the forecast period.
- Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies. Moreover, they are focusing on e-commerce for distribution.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Thông tin liên hệ
: mahikthane97
:
:
:
:
